Search
apolipoprotein B100 (apoB100)
Function:
- apo B100 is involved in lipid transport & clearance
- ligand for the LDL receptor
- apo B100 is the major inhibitor of membrane binding & pore insertion activity of perforin
Structure:
- recognition site for the LDL receptor is in the C-terminal portion of the protein
Expression:
- hepatic synthesis of apoB100 is about 10 mg/kg/day
Related
apolipoprotein-B gene
General
apolipoprotein B
Properties
SIZE: entity length = 4563 aa
MW = 516 kD
COMPARTMENT: plasma
MOTIF: signal sequence {1-27}
binding site
SITE: 32-126
FOR-BINDING-OF: heparin
MOTIF: N-glycosylation site {N34}
cysteine residue {C39}
MODIFICATION: cysteine residue {C88}
Vitellogenin {46-672}
MOTIF: cysteine residue {C78}
MODIFICATION: cysteine residue {C97}
cysteine residue {C88}
MODIFICATION: cysteine residue {C39}
cysteine residue {C97}
MODIFICATION: cysteine residue {C78}
N-glycosylation site {N185}
cysteine residue {C186}
MODIFICATION: cysteine residue {C212}
cysteine residue {C212}
MODIFICATION: cysteine residue {C186}
binding site
SITE: 232-306
FOR-BINDING-OF: heparin
cysteine residue {C245}
MODIFICATION: cysteine residue {C261}
cysteine residue {C261}
MODIFICATION: cysteine residue {C245}
cysteine residue {C385}
MODIFICATION: cysteine residue {C390}
cysteine residue {C390}
MODIFICATION: cysteine residue {C385}
cysteine residue {C478}
MODIFICATION: cysteine residue {C513}
cysteine residue {C513}
MODIFICATION: cysteine residue {C478}
binding site
SITE: 902-959
FOR-BINDING-OF: heparin
MOTIF: Ser phosphorylation site {S928}
cysteine residue {C966}
MODIFICATION: cysteine residue {C976}
cysteine residue {C976}
MODIFICATION: cysteine residue {C966}
N-glycosylation site {N983}
cysteine residue {C1112}
MODIFICATION: palmitate
COMPARTMENT: membrane
N-glycosylation site {N1368}
N-glycosylation site {N1377}
N-glycosylation site {N1523}
binding site
SITE: 2043-2178
FOR-BINDING-OF: heparin
N-glycosylation site {N2239}
binding site
FOR-BINDING-OF: lipid
N-glycosylation site {N2560}
N-glycosylation site {N2779}
N-glycosylation site {N2982}
N-glycosylation site {N3101}
binding site
SITE: 3161-3236
FOR-BINDING-OF: heparin
MOTIF: basic region {3174-3184}
cysteine residue {C3194}
MODIFICATION: cysteine residue {C3324}
N-glycosylation site {N3224}
cysteine residue {C3324}
MODIFICATION: cysteine residue {C3194}
N-glycosylation site {N3336}
N-glycosylation site {N3358}
LDL receptor binding {3373-3393}
binding site
SITE: 3383-3516
FOR-BINDING-OF: heparin
MOTIF: basic region {3386-3394}
N-glycosylation site {N3411}
N-glycosylation site {N3465}
N-glycosylation site {N3895}
N-glycosylation site {N4237}
N-glycosylation site {N4431}
Ser phosphorylation site {S4507}
MISC-INFO: 1/2life 2-5 DAYS
References
- Mendelian Inheritance in Man (1990) MIM#107370
- Primary Hyperlipoproteinemias, Steiner & Shafrir
(eds), McGraw Hill, NY, 1991, pg 25
- UniProt :accession P04114
Component-of
oxidized low density lipoprotein (oxidized LDL, oxLDL)